Company intelligence / Profile preview

Apollo Medical Optics

Taipei City, Taiwanapollomedicaloptics.com ↗

Ownership: Private
Development stage: Commercial

Overview

Apollo Medical Optics has developed and commercialized the ApolloVue S100 Image System—a non-invasive full-field optical coherence tomography device that provides real-time cellular-resolution images of external human tissue. The S100 received US FDA 510(k) clearance in September 2020 and Taiwan TFDA clearance in early 2021. The company’s systems are designed to reduce the need for skin biopsies by enabling high-resolution visualization of skin microstructure at the point of care.

Therapeutic areas: OtherDermatologyOphthalmologyGastroenterology
Modalities: DeviceNon-pharmacological therapy (imaging)
Industry: Pathology

Partnerships

No major pharmaceutical or biotech partnerships publicly disclosed as of June 2025.

Beyond the preview

Go deeper on Apollo Medical Optics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Apollo Medical Optics.

Explore the full profile